Autoimmun-Polyendocrinopathie-Syndrom 3

HALL R et al. (1962) A study of the parents of patients with Hashimoto's disease.

Tomer Y et al. (1999) Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions.

Klintschar M et al. (2001) Evidence of fetal microchimerism in Hashimoto's thyroiditis.

Alkhateeb A et al. (2002) Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2.

Ochi H et al. (2002) Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy.

Vaidya B et al. (2002) The genetics of autoimmune thyroid disease.

Allen EM et al. (2003) A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: replication of genetic linkage on chromosome 5q11.2-q14.3.

Akamizu T et al. (2003) Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients.

Tomer Y et al. (2003) Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families.

Jacobson DL et al. (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

VOLPE R et al. (1963) Genetic factors in Hashimoto's struma.

HALL R et al. (1964) PATERNAL TRANSMISSION OF THYROID AUTOIMMUNITY.

MASI AT et al. (1965) HASHIMOTO'S DISEASE. AN EPIDEMIOLOGICAL CRITIQUE.

Barbero P et al. (2004) Choanal atresia associated with prenatal methimazole exposure: three new patients.

Invernizzi P et al. (2005) X chromosome monosomy: a common mechanism for autoimmune diseases.

Tomer Y et al. (1993) Infection, thyroid disease, and autoimmunity.

Hollowell JG et al. (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Tomer Y et al. (1997) The immunogenetics of autoimmune diabetes and autoimmune thyroid disease.

Valenzise M et al. (2017) Epidemiological and clinical peculiarities of polyglandular syndrome type 3 in pediatric age.

Criswell LA et al. (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.

Caturegli P et al. (2000) Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid.

Shirasawa S et al. (2004) SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease.

Sakai K et al. (2001) Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese.

Flesch BK et al. (2014) HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III.

Tomer Y et al. (2015) Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetes.

Horie I et al. (2012) Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population.

Dittmar M et al. (2010) Genetics of the autoimmune polyglandular syndrome type 3 variant.

Ueda H et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Phillips D et al. (1991) Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin--studies in families not selected for autoimmune thyroid disease.

Phillips D et al. (1990) Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase.

Shuper A et al. (1987) Familial Hashimoto's thyroiditis with kidney impairment.

None (1985) Familial "hashitoxic' periodic paralysis.

Conaway DH et al. (1985) The familial occurrence of lymphocytic thyroiditis in borzoi dogs.

Matsuura N et al. (1980) Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins.

Giordano C et al. (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis.